Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma
- PMID: 20719886
- PMCID: PMC3339633
- DOI: 10.1158/0008-5472.CAN-10-0815
Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma
Abstract
Allergy history has been consistently inversely associated with glioma risk. Two serologic markers, soluble CD23 (sCD23) and soluble CD14 (sCD14), are part of the innate and adaptive humoral immune systems and modulate allergic responses in opposite directions, with sCD23 enhancing and sCD14 blunting inflammatory responses. We measured sCD23 and sCD14 in serum from blood that was drawn at a single time point from 1,079 glioma patients postdiagnosis and 736 healthy controls. Glioma was strongly associated with high sCD14 [highest versus lowest quartile odds ratio (OR), 3.94; 95% confidence interval (95% CI), 2.98-5.21] and low sCD23 (lowest versus highest quartile OR, 2.5; 95% CI, 1.89-3.23). Results were consistent across glioma histologic types and grades, but were strongest for glioblastoma. Whereas temozolomide treatment was not associated with either sCD14 or sCD23 levels among cases, those taking dexamethasone had somewhat lower sCD23 levels than those not taking dexamethasone. However, sCD23 was associated with case status regardless of dexamethasone treatment. These results augment the long-observed association between allergies and glioma and support a role for the innate and adaptive humoral functions of the immune system, in particular immunoregulatory proteins, in gliomagenesis.
© 2010 AACR.
Figures

Similar articles
-
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.Int J Cancer. 2009 Aug 1;125(3):680-7. doi: 10.1002/ijc.24369. Int J Cancer. 2009. PMID: 19408307 Free PMC article.
-
Soluble CD23 in allergic diseases.Arch Immunol Ther Exp (Warsz). 1999;47(4):251-5. Arch Immunol Ther Exp (Warsz). 1999. PMID: 10483874
-
Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season.Allergy Asthma Proc. 1999 Mar-Apr;20(2):119-25. doi: 10.2500/108854199778612590. Allergy Asthma Proc. 1999. PMID: 10209690
-
Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin's lymphomas: evidence from a meta-analysis.Ann Hematol. 2018 Aug;97(8):1317-1325. doi: 10.1007/s00277-018-3349-y. Epub 2018 May 11. Ann Hematol. 2018. PMID: 29750316
-
Soluble CD14: role in atopic disease and recurrent infections, including otitis media.Curr Allergy Asthma Rep. 2007 Nov;7(6):436-43. doi: 10.1007/s11882-007-0067-2. Curr Allergy Asthma Rep. 2007. PMID: 17986374 Review.
Cited by
-
Immune genes are associated with human glioblastoma pathology and patient survival.BMC Med Genomics. 2012 Sep 14;5:41. doi: 10.1186/1755-8794-5-41. BMC Med Genomics. 2012. PMID: 22980038 Free PMC article.
-
Serum soluble CD14 is a potential prognostic indicator of recurrence of human breast invasive ductal carcinoma with Her2-enriched subtype.PLoS One. 2013 Sep 25;8(9):e75366. doi: 10.1371/journal.pone.0075366. eCollection 2013. PLoS One. 2013. PMID: 24086515 Free PMC article.
-
Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.Int J Cancer. 2014 May 1;134(9):2199-210. doi: 10.1002/ijc.28535. Epub 2013 Oct 31. Int J Cancer. 2014. PMID: 24127236 Free PMC article.
-
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):282-90. doi: 10.1158/1055-9965.EPI-15-0847. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26908595 Free PMC article.
-
Circulating biomarkers for gliomas.Nat Rev Neurol. 2015 Oct;11(10):556-66. doi: 10.1038/nrneurol.2015.171. Epub 2015 Sep 15. Nat Rev Neurol. 2015. PMID: 26369507 Review.
References
-
- Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer. 2003;106:423–8. - PubMed
-
- Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer. 2002;98:609–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials